Medication info
Traina Tablets 5 mg (Linagliptin Besilate)

Traina Tablets 5 mg (Linagliptin Besilate)

Prescription medicationTablet
Ingredient · strength
Linagliptin Besylate›6.67mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Pink round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202400699 · Approved 2024.03.29 · Insurance code 694004230

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
The recommended dose of this medicine is 5mg of linagliptin once daily (6.67mg of linagliptin besylate). It may be taken regardless of meals. When used in combination with insulin or an insulin secretagogue (such as a sulfonylurea), lower doses of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
View approved original text

This medication is used to enhance blood sugar control in patients with type 2 diabetes, as an adjunct to diet and exercise. It is effective as monotherapy and can be expected to provide better blood sugar management when combined with other treatments.

Dosage and Administration

Adult dosage

The recommended dose of this medicine is 5mg of linagliptin once daily (6.67mg of linagliptin besylate). It may be taken regardless of meals. When used in combination with insulin or an insulin secretagogue (such as a sulfonylurea), lower doses of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.

Precautions

This medication should not be used in patients with allergies to the active ingredient or any other components. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. Caution is required as the risk of hypoglycemia may increase when used with medications that can cause hypoglycemia, such as insulin or sulfonylureas. Use is not recommended in patients with severe heart failure, and those with mild heart failure should use it cautiously. Symptoms of acute pancreatitis may occur; if continuous abdominal pain occurs, discontinue the medication immediately and consult a doctor. Dermatological adverse reactions such as bullous pemphigoid may occur; immediately inform healthcare providers if any skin abnormalities arise. Hypoglycemia may occur during treatment, so monitor symptoms and adjust dosage if necessary. Safety has not been established for use in pregnant or breastfeeding women; caution is advised, especially during breastfeeding. Safety and efficacy have not been sufficiently confirmed in pediatric or adolescent patients. There are no special dosage adjustments for the elderly, nor for patients with impaired kidney or liver function. In cases of overdose, it is important to take measures to prevent absorption in the gastrointestinal tract and receive appropriate treatment based on symptoms. Medications should be stored out of reach of children, and it is advisable to avoid transferring them to other containers.

Side effects

  • Hypoglycemia
  • nasopharyngitis
  • hypersensitivity
  • angioedema
  • urticaria
  • pancreatitis
  • constipation
  • oral ulcer
  • rash
  • dermatitis herpetiformis
Show 121 more
  • weight gain
  • increased lipase
  • increased amylase
  • dyspepsia
  • edema
  • facial edema
  • peripheral edema
  • weight loss
  • increased appetite
  • constipation
  • abdominal pain
  • enterocolitis
  • bowel obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuritis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorder
  • Alzheimer's dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • liver metastasis
  • acute leukemia
  • basal cell carcinoma
  • non-small cell lung cancer
  • malignant pericardial effusion
  • gastric cancer
  • rectal cancer
  • pancreatic cancer
  • meniscus injury
  • pneumoconiosis
  • congestive heart failure
  • angina
  • acute myocardial infarction
  • unstable angina
  • cardiac arrest
  • diabetic retinopathy
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • dizziness
  • renal transplant failure
  • anemia
  • nausea
  • diarrhea
  • vomiting
  • gastroesophageal reflux disease
  • gastritis
  • lightheadedness
  • sensory impairment
  • chest discomfort
  • weakness
  • epistaxis
  • oropharyngeal pain
  • voice disorder
  • allergic rhinitis
  • exertional dyspnea
  • wet cough
  • runny nose
  • pulmonary mass
  • arthralgia
  • osteoporosis
  • joint disease
  • musculoskeletal discomfort
  • myositis
  • myalgia
  • soft tissue mass
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • androgenic alopecia
  • diabetic foot disease
  • hyperhidrosis
  • hair loss
  • dermatitis
  • anxiety
  • mood disorder
  • insomnia
  • depression
  • contusion
  • bone contusion
  • concussion
  • bone fracture
  • hand fracture
  • laceration
  • palpitations
  • dry eye
  • glaucoma
  • cataract
  • ocular discomfort
  • allergic conjunctivitis
  • polyuria
  • proteinuria
  • stress urinary incontinence
  • hematuria
  • hypotension
  • flushing
  • fatty liver disease
  • cholelithiasis
  • hearing impairment
  • erectile dysfunction
  • goiter
  • pruritus
  • hypertension
  • benign prostatic hyperplasia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to store it at a temperature between 1 and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and ensure safe use.

Appearance and packaging

Appearance

Pink round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.